
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.930 | 3.930 | 0.000 |
Stocks | 93.850 | 93.850 | 0.000 |
Bonds | 3.290 | 3.290 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 61.598 | 24.527 |
Price to Book | 4.285 | 3.017 |
Price to Sales | 6.052 | 4.048 |
Price to Cash Flow | 20.046 | 16.970 |
Dividend Yield | 0.384 | 1.993 |
5 Years Earnings Growth | 4.239 | 9.514 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.670 | 95.706 |
Consumer Defensive | 3.310 | 3.655 |
Industrials | 0.010 | 0.688 |
Technology | 0.010 | 0.545 |
Number of long holdings: 61
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.81 | 48.38 | -0.25% | |
Innovent Biologics | KYG4818G1010 | 8.55 | 47.75 | +9.27% | |
Hutchison China | KYG4672N1198 | 8.41 | 208.00 | +5.85% | |
Akeso Inc Ordinary Shares | - | 8.35 | - | - | |
Keymed Biosciences Inc | - | 8.32 | - | - | |
Sichuan Kelun Biotech | CNE1000062J1 | 7.87 | 302.00 | +7.55% | |
Beigene | CNE100005XT6 | 6.24 | 235.30 | +6.51% | |
RemeGen | CNE100005B03 | 5.96 | 46.34 | -0.73% | |
Hansoh Pharmaceutical Group | KYG549581067 | 3.98 | 22.60 | +2.96% | |
CSPC Innovation | CNE100003K04 | 3.11 | 41.51 | +0.24% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BOC Income Mixed Securities Inves A | 2.06B | 7.72 | -2.61 | 10.02 | ||
BOC Income Mixed Securities Inves H | 2.06B | 7.71 | -2.61 | - | ||
BOC Sustainable Growth MixSec inv A | 1.35B | -0.86 | -11.67 | 3.44 | ||
BOC Sustain Growth Mixed Sec inv H | 1.35B | -0.90 | -11.72 | - | ||
BOC New Return Alloc | 1.23B | -0.74 | 0.94 | 5.62 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review